Showing results (631-640 of 1,194) with videos related to

Sort By:
Pageof 120
JACC. Heart Failure|January 17, 2023
Treatment Differences in Medical Therapy for Heart Failure With Reduced Ejection Fraction Between Sociodemographic GroupsCeleste Witting, Jimmy Zheng, Rebecca L Tisdale, et al.
JACC. Heart Failure|December 1, 2022
Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF TrialMichael R Zile, Mandeep R Mehra, Anique Ducharme, et al.
JACC. Heart Failure|November 30, 2019
MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPHASIS-HF, and TOPCATJoão Pedro Ferreira, Xavier Rossello, Romain Eschalier, et al.
JACC. Heart Failure|February 11, 2019
Identification of Frailty in Chronic Heart FailureShirley Sze, Pierpaolo Pellicori, Jufen Zhang, et al.
JACC. Heart Failure|February 11, 2019
Income Inequality and Outcomes in Heart Failure: A Global Between-Country AnalysisPooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.
JACC. Heart Failure|July 11, 2021
Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF: The PARAGON-HF TrialMauro Gori, Michele Senni, Brian Claggett, et al.
JACC. Heart Failure|December 14, 2020
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACTClaudio Rapezzi, Perry Elliott, Thibaud Damy, et al.
JACC. Heart Failure|January 1, 2021
Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19Ankeet S Bhatt, Karola S Jering, Muthiah Vaduganathan, et al.
JACC. Heart Failure|July 30, 2021
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM StudyJuan Antonio Requena-Ibáñez, Carlos G Santos-Gallego, Anderly Rodriguez-Cordero, et al.
JACC. Heart Failure|September 10, 2013
Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertensionEvan L Brittain, Meredith E Pugh, Lisa A Wheeler, et al.
Pageof 120